Add to Favourites
To login click here
The global AI in genomics market is expected to generate $9.8 billion by 2031, witnessing a CAGR of 40.6% from 2022 to 2031. This growth is driven by the rise in applications of AI in drug discovery and development and advancements in artificial intelligence technology. The machine learning segment is estimated to maintain its leadership status throughout the forecast period due to its ability to integrate genomic data with other types of data.
